Thrive Capital Management (Pennsylvania)’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Buy |
25,606
+10,396
| +68% | +$1.59M | 1.23% | 15 |
|
|
2025
Q1 | $2.52M | Sell |
15,210
-6,615
| -30% | -$1.1M | 1.51% | 9 |
|
|
2024
Q4 | $3.16M | Buy |
21,825
+5,764
| +36% | +$834K | 1.45% | 17 |
|
|
2024
Q3 | $2.6M | Sell |
16,061
-1,229
| -7% | -$199K | 1.23% | 13 |
|
|
2024
Q2 | $2.53M | Buy |
17,290
+3,722
| +27% | +$544K | 1.15% | 14 |
|
|
2024
Q1 | $2.15M | Buy |
13,568
+6,183
| +84% | +$978K | 1.14% | 13 |
|
|
2023
Q4 | $1.16M | Buy |
7,385
+316
| +4% | +$49.5K | 0.62% | 44 |
|
|
2023
Q3 | $1.1M | Sell |
7,069
-191
| -3% | -$29.7K | 0.61% | 44 |
|
|
2023
Q2 | $1.2M | Buy |
7,260
+798
| +12% | +$132K | 0.69% | 44 |
|
|
2023
Q1 | $991K | Buy |
6,462
+189
| +3% | +$29K | 0.63% | 44 |
|
|
2022
Q4 | $1.11M | Buy |
6,273
+620
| +11% | +$110K | 0.72% | 38 |
|
|
2022
Q3 | $923K | Sell |
5,653
-6
| -0.1% | -$980 | 0.62% | 41 |
|
|
2022
Q2 | $1.01M | Sell |
5,659
-356
| -6% | -$63.2K | 0.7% | 39 |
|
|
2022
Q1 | $1.07M | Sell |
6,015
-3,471
| -37% | -$615K | 0.64% | 39 |
|
|
2021
Q4 | $1.62M | Sell |
9,486
-1,704
| -15% | -$292K | 1.06% | 21 |
|
|
2021
Q3 | $1.81M | Sell |
11,190
-451
| -4% | -$72.8K | 1.33% | 18 |
|
|
2021
Q2 | $1.92M | Buy |
11,641
+288
| +3% | +$47.5K | 1.49% | 14 |
|
|
2021
Q1 | $1.87M | Sell |
11,353
-33
| -0.3% | -$5.42K | 1.74% | 19 |
|
|
2020
Q4 | $1.79M | Buy |
+11,386
| New | +$1.79M | 1.91% | 19 |
|